2 ms·
Sure, you could probably accelerate review from 3 months to a few weeks. The FDA is familiar with rolling submissions where you send data to them as it becomes
by refurb 7y ago
Sure, you could probably accelerate review from 3 months to a few weeks. The FDA is familiar with rolling submissions where you send data to them as it becomes available.
3 days? That's really aggressive.